Show
Sort by
-
- Journal Article
- A1
- open access
The human fetal thymus generates invariant effector γδ T cells
-
- Miscellaneous
- open access
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial (vol 21, 981, 2020)
-
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19 : a nationwide observational study of 8075 participants
-
Clinical work in language-discordant Emergency Department consultations